AI-Powered Biotech Firm Tianwu Tech Launches MatwingsVenus™: A Conversational Protein Design Agent Backed by 10B-Data and 200+ Tools

Apr 24, 2026 18:34 CST Updated 18:34

Matwings Technology

AI Protein Design Service Provider

On April 24, AI bio-manufacturing enterprisesMatwings TechnologyPublishConversational Protein Research and Development AgentMatwingsVenus™ (Matwings™)。

The platform canDialogue Agent CompletedIndustry Research, Tag Database Retrieval, Protein Design, Automated Experimental Validation, Expert Online CollaborationWork, etc., to achieve"Design is Verification, Verification is Iteration"Intelligent R&D.

The following video is sourced from

Matwings Technology

ExperienceAddress:https://matvenus.com/

It is reported that the platformSupportBillion-Level Real-Tag Protein Data Retrieval, Integration200+Protein design tools,50+Experts certified by the platform, and30+ Optimized by experts in various fields Skills。

And achievedDeep Collaboration between Cloud Design and Physical ExperimentsSame,FormationThe iterative "conversational dry-wet closed loop" driven by computational wet experiments and wet experiments feeding back into computations hasViaImmune Modulatory Receptor Targets, Sweet Protein Monellin...and other innovative drugs and synthetic biology fields, completing multiple cases.

SJTU Team Holds a Billion-Level Protein Dataset

Matwings Technology was founded in 2021 and is aAI-Driven Full-Stack Protein R&D Platform Company.ByShanghai Jiao Tong UniversityTeam Creation: One of the earliest companies in China to deploy AI protein large models.

Currently, the company has builtUltra-large-scale Protein Sequence Dataset/Label LibraryVenus (Morning Star), bringing together nearly10 billionProtein sequence, containing 6.5 billion tags with environmental factors such as temperature, pressure, and pH.

And on this basis, a general large model for protein design was built.AIACCLBIO®, realizing the precise design of functional proteins directly targeting industrial needs.

The company aims to fully integrate AI into industrial application scenarios, and develop various biological products based on protein chips more quickly and efficiently.Such as innovative drugs, health and wellness, agriculture, functional foods, bio-based materials, etc.

Currently, four rounds of financing have been completed, with investors includingCNPC Kunlun Capital, Shanghai Future Industry Fund, Qiming Venture CapitalAnd many other well-known investment companies.

Recommended Reading